Euclidean Capital LLC Long-Term Concentrated

CIK: 0001825034 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value ($000): $107,716 (100.0% shares, 0.0% debt)

Holdings (10)

— 23ANDME HOLDING CO 27.2%

Value ($000) $29,295 Shares 10,243,122 Est. Cost $3.83 Unrealized —

PMVP PMV PHARMACEUTICALS INC 25.8%

Value ($000) $27,809 Shares 2,336,909 Est. Cost $39.23 Unrealized -63.2%

FHTX FOGHORN THERAPEUTICS INC 10.0%

Value ($000) $10,822 Shares 1,261,261 Est. Cost $19.16 Unrealized -32.8%

— RAPT THERAPEUTICS INC 9.7%

Value ($000) $10,416 Shares 432,900 Est. Cost $19.75 Unrealized —

— NGM BIOPHARMACEUTICALS INC 9.1%

Value ($000) $9,766 Shares 746,674 Est. Cost $30.30 Unrealized —

ALEC ALECTOR INC 8.6%

Value ($000) $9,279 Shares 980,894 Est. Cost $12.43 Unrealized -13.0%

FFBC FIRST FINL BANCORP OH 3.4%

Value ($000) $3,659 Shares 173,576 Est. Cost $12.77 Unrealized +48.3%

TNYA TENAYA THERAPEUTICS INC 2.5%

Value ($000) $2,656 Shares 915,705 Est. Cost $21.49 Unrealized -78.3%

ORIC ORIC PHARMACEUTICALS INC 2.2%

Value ($000) $2,392 Shares 747,550 Est. Cost $28.69 Unrealized -86.0%

— SURROZEN INC 1.5%

Value ($000) $1,622 Shares 802,963 Est. Cost $7.08 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	23ANDME HOLDING CO	10,243,122	$29,295	27.2%	$3.83	—	CLASS A COM	90138Q108
PMVP	PMV PHARMACEUTICALS INC	2,336,909	$27,809	25.8%	$39.23	-63.2%	COM	69353Y103
FHTX	FOGHORN THERAPEUTICS INC	1,261,261	$10,822	10.0%	$19.16	-32.8%	COM	344174107
—	RAPT THERAPEUTICS INC	432,900	$10,416	9.7%	$19.75	—	COM	75382E109
—	NGM BIOPHARMACEUTICALS INC	746,674	$9,766	9.1%	$30.30	—	COM	62921N105
ALEC	ALECTOR INC	980,894	$9,279	8.6%	$12.43	-13.0%	COM	014442107
FFBC	FIRST FINL BANCORP OH	173,576	$3,659	3.4%	$12.77	+48.3%	COM	320209109
TNYA	TENAYA THERAPEUTICS INC	915,705	$2,656	2.5%	$21.49	-78.3%	COM	87990A106
ORIC	ORIC PHARMACEUTICALS INC	747,550	$2,392	2.2%	$28.69	-86.0%	COM	68622P109
—	SURROZEN INC	802,963	$1,622	1.5%	$7.08	—	COM	86889P109